| Financial Year |
March 31 2023 |
| Monetary Funds |
115,134,185.41 |
| Held-for-trading Financial Assets |
130,808,908.17 |
| Notes Receivable |
-- |
| Accounts Receivable |
37,746,015.05 |
| Advances to Suppliers |
61,028,358.65 |
| Other Receivables |
14,496,377.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
133,846,286.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,516,645.42 |
| Total Current Assets |
494,681,897.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
14,394,741.29 |
| Investment Properties |
-- |
| Fixed Assetes |
17,183,046.16 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,623,918.57 |
| R&D expenses |
224,205.46 |
| Goodwill |
76,206,504.15 |
| Long-Term Deferred and Prepaid Expenses |
3,115,375.25 |
| Deferred Income Tax Assets |
1,978,988.90 |
| Other Non-Current Assets |
25,979.72 |
| Sub-Total of Non-Current Assets |
141,753,189.10 |
| Total Assets |
636,435,086.17 |
| Short-Term Loans |
33,192,567.28 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
13,671,052.92 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,859,138.50 |
| Taxes Payable |
14,551,822.60 |
| Interest Payable |
-- |
| Dividend Payable |
800.00 |
| Other payables |
11,642,978.21 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,788,590.26 |
| Other Current Liabilities |
712,049.88 |
| Sub-Total of Current Liabilities |
92,871,327.46 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,293,425.40 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
12,476,292.65 |
| Total Liabilities |
105,347,620.11 |
| Paid-In Capital(Or Share Stock) |
230,000,000.00 |
| Capital Surplus |
523,310,408.84 |
| Surplus Reserve |
37,406,629.52 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-365,923,430.13 |
| Minority Stockholder's Interest |
106,293,857.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
424,793,608.23 |
| Owner's Equity（Stockholder's Equity） |
531,087,466.06 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
636,435,086.17 |
